ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
18 hedge funds and large institutions have $813K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
20% more funds holding
Funds holding: 15 → 18 (+3)
54% less capital invested
Capital invested by funds: $1.78M → $813K (-$968K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$52.5K |
| 2 |
Renaissance Technologies
New York
|
+$27.9K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$28K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$3.57K |
| 3 |
EWM
Edge Wealth Management
New York
|
-$1K |
| 4 |
Morgan Stanley
New York
|
-$24 |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
-$16 |
ECTE Hedge Fund Activity: Q2 2016 in Review
18 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q2 2016, worth a combined $813K — down 54% from $1.78M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ECTE positions and 2 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $52.5K. The largest seller was Goldman Sachs, exiting entirely with an estimated $28K sold.
- 18 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q2 2016, up from 15 in Q1 2016.
- Funds reported $813K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q2 2016, down 54% quarter-over-quarter.
- 6 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q2 2016 and 2 closed out, a net change of +4 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q2 2016 was Virtu KCG Holdings, an estimated $52.5K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q2 2016 was Goldman Sachs, an estimated $28K sold.
Based on aggregated 13F filings for Q2 2016.